ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,91
-1,31%
Dow Jones
41 657,30
-0,61%
DAX
22 328,77
-1,23%
Brent Oil
69,49
0,65%
Bitcoin
82 967,43
5,72%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. PharmaCyte Biotech Inc (PMCB) Cours

PharmaCyte Biotech Inc

PharmaCyte Biotech Inc (PMCB)

NASDAQ
1,68
-0,10
( -5,62% )
Mis à jour : 18:57:31
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
1,68
Prix Achat
1,68
Prix Vente
1,78
Volume échangé
3 131
1,67 Fourchette du Jour 1,79
1,39 Plage de 52 semaines 2,58
Cap du marché
11,706M
Clôture Veille
1,78
Ouverture
1,79
Dernière Transaction
1
@
1.73
Dernière heure de transaction
19:08:44
Volume financier
US$ 5 318
VWAP
1,6986
Volume moyen (3 m)
18 512
Actions en circulation
6 968 134
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,68
Bénéfice par action (BPA)
-2,47
Chiffre d'affairess
-
Bénéfice net
-17,24M

À propos de PharmaCyte Biotech Inc

PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technol... PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Medicinal Chems,botanicl Pds
Site Web
ir.pharmacyte.com
Siège social
Reno, Nevada, USA
Fondé
2018
PharmaCyte Biotech Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker PMCB. Le dernier cours de clôture d'PharmaCyte Biotech était de US$1,78. Au cours de la dernière année, les actions de PharmaCyte Biotech ont été négociées dans une fourchette de prix de US$ 1,39 à US$ 2,58.

PharmaCyte Biotech compte actuellement 6 968 134 actions en circulation. La capitalisation boursière d'PharmaCyte Biotech est de US$12,40 million. PharmaCyte Biotech a un ratio cours/bénéfice (ratio PE) de -0.68.

PMCB Dernières nouvelles

Plus de nouvelles

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
il y a 22 heures
PMCB (-5,62%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
il y a 23 heures
PMCB (-5,62%)

Form 8-K - Current report
Edgar (US Regulatory)
26 Février 2025
PMCB (-5,62%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 Décembre 2024
PMCB (-5,62%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
04 Décembre 2024
PMCB (-5,62%)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Edgar (US Regulatory)
13 Novembre 2024
PMCB (-5,62%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
13 Août 2024
PMCB (-5,62%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.117.006369426751.571.81991.5792441.76814466CS
40.1711.25827814571.511.91.4635286911.71602959CS
120.010.598802395211.671.91.45185121.66076233CS
26-0.03-1.754385964911.712.42291.45269921.76913126CS
52-0.37-18.04878048782.052.581.39245841.94388117CS
156-0.47-21.86046511632.153.231.39857872.34042771CS
260-1.4-45.45454545453.089.981.395945546.01257374CS

PMCB - Frequently Asked Questions (FAQ)

What is the current PharmaCyte Biotech share price?
The current share price of PharmaCyte Biotech is US$ 1,68
How many PharmaCyte Biotech shares are in issue?
PharmaCyte Biotech has 6 968 134 shares in issue
What is the market cap of PharmaCyte Biotech?
The market capitalisation of PharmaCyte Biotech is USD 12,4M
What is the 1 year trading range for PharmaCyte Biotech share price?
PharmaCyte Biotech has traded in the range of US$ 1,39 to US$ 2,58 during the past year
What is the PE ratio of PharmaCyte Biotech?
The price to earnings ratio of PharmaCyte Biotech is -0,68
What is the reporting currency for PharmaCyte Biotech?
PharmaCyte Biotech reports financial results in USD
What is the latest annual profit for PharmaCyte Biotech?
The latest annual profit of PharmaCyte Biotech is USD -17,24M
What is the registered address of PharmaCyte Biotech?
The registered address for PharmaCyte Biotech is 401 RYLAND ST STE 200-A, RENO, NEVADA, 89502
What is the PharmaCyte Biotech website address?
The website address for PharmaCyte Biotech is ir.pharmacyte.com
Which industry sector does PharmaCyte Biotech operate in?
PharmaCyte Biotech operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RAYRaytech Holding Ltd
US$ 1,74
(100,00%)
91,61M
SYRSSyros Pharmaceuticals Inc
US$ 0,1672
(82,53%)
658,73M
TSVT2seventy bio Inc
US$ 4,945
(76,61%)
29,55M
TNONTenon Medical Inc
US$ 1,8901
(51,21%)
33,08M
HSAIHesai Group
US$ 23,675
(47,88%)
23,47M
WCTWellchange Holdings Company Limited
US$ 0,7248
(-71,12%)
29,27M
ARVNArvinas Inc
US$ 8,59
(-51,08%)
13,75M
LZMHLZ Technology Holdings Ltd
US$ 8,34
(-46,74%)
517,87k
SPGCSacks Parente Golf Inc
US$ 0,1034
(-35,42%)
31,87M
MDCXMedicus Pharma Ltd
US$ 2,5295
(-25,60%)
93,44k
SYRSSyros Pharmaceuticals Inc
US$ 0,1671
(82,42%)
658,75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0389
(16,12%)
388,47M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8,10
(9,76%)
255,7M
NVDANVIDIA Corporation
US$ 110,31
(3,11%)
254,15M
CUTRCutera Inc
US$ 0,1089
(-15,25%)
209,74M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
PMCB
PharmaCyte Biotech
AMEX
FXH
First Trust Health Care ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces